Linked Life Data

18420951

Source:http://linkedlifedata.com/resource/pubmed/id/18420951

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-5-28
pubmed:abstractText
Central retinal artery occlusion results in acute visual loss with poor spontaneous recovery. Current standard therapies do not alter the natural history of disease. Several open-label clinical studies using continuous infusion of thrombolytic agents have suggested that local intraarterial fibrinolysis (LIF) is efficacious in the treatment of central retinal artery occlusion. The aim is to compare the visual outcome in patients with acute central retinal artery occlusion of presumed thromboembolic etiology treated with LIF administered in aliquots with that of patients treated with standard therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1524-4628
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1746-50
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience.
pubmed:affiliation
Department of Neurology, Meyer 6-109, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA. ealdrich@jhmi.edu
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study